ATAI vs CUBE · rev $308.0K vs P/E 25, rev $1.07B
ATAI Life Sciences BV (ATAI) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported ATAI revenue for 2024-12-31 was $308.0K. Net income was -$150.0M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. ATAI currently screens at market cap $555.8M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
ATAI currently screens at market cap $555.8M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the ATAI and CUBE stock pages for the full models.
Not investment advice.